News

Biocair

Innovative technologies...

Publication date : 2019-10-29

The project BioCAIRBIOmarkers of T-Cell Activity in tumors and Immunotherapy Response – is financed by European funds (FEDER).

Diaclone brings its competences in antibody development and engineering to this project, with the support of the mAbexperts team.

More information here or visit our collaborations page: https://www.diaclone.com/about/collaborations

Other news

  • Corona
    Human IL-6 cytokine, a useful tool for Coronavirus disease (COVID-19) and Immunotherapy research
    Publication date : 2020-03-20
    DIACLONE provides a large panel of products for the quantification of human IL-6 and other human cytokines. Read more
  • Recrute
    Diaclone recrute!
    Publication date : 2020-03-11
    Diaclone recherche un poste d'assistant(e) administratif(ve). Read more
  • ELISpot 30 years
    Discover Diaclone ELISpot
    Publication date : 2020-02-06
    C'était il y a 30 ans.... Read more
  • New Products
    New mAbs join the Diaclone Catalogue
    Publication date : 2020-02-04
    New Monoclonal Antibodies from Diaclone! Read more
  • Diaclone's Toolbox
    Use Diaclone’s Toolbox to monitor your CAR-T cell responses
    Publication date : 2019-12-16
    In vitro studies with Diaclone’s Toolbox to monitor the risks linked to immunotherapy.... Read more
  • Toolbox
    Diaclone's Toolbox for your Car-T Development
    Publication date : 2019-11-12
    Our Monoclonal Antibodies and ELISpot range are valuable tools for your CAR-T research. Read more
  • CAR-T development
    CAR-T development
    Publication date : 2019-10-01
    How can Diaclone support your CAR-T development? Read more
  • Diaclone est partenaire d’un projet européen d’envergure associant une douzaine de partenaires de la région de Besançon.
    MiMédi Project
    Publication date : 2019-08-29
    Diaclone is a partner in a major European project involving a dozen partners from the Besançon region. Read more

Product search